MicroRNAs contribute to breast cancer invasiveness
I Fridrichova, I Zmetakova - Cells, 2019 - mdpi.com
Cancer statistics in 2018 highlight an 8.6 million incidence in female cancers, and 4.2 million
cancer deaths globally. Moreover, breast cancer is the most frequent malignancy in females …
cancer deaths globally. Moreover, breast cancer is the most frequent malignancy in females …
[HTML][HTML] Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancer
NM Ghahhari, S Babashah - European journal of cancer, 2015 - Elsevier
The WNT/β-catenin signalling implies its significance in maintaining an epithelial cell
phenotype, proper cell–cell junctions, and tissue homeostasis. Dysregulation of the …
phenotype, proper cell–cell junctions, and tissue homeostasis. Dysregulation of the …
Recent advances in microfluidic platforms applied in cancer metastasis: Circulating tumor cells'(CTCs) isolation and tumor‐on‐a‐chip
Cancer remains the leading cause of death worldwide despite the enormous efforts that are
made in the development of cancer biology and anticancer therapeutic treatment …
made in the development of cancer biology and anticancer therapeutic treatment …
Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks
J Vaquero, N Guedj, A Clapéron… - Journal of …, 2017 - Elsevier
Cholangiocarcinoma (CCA) is an aggressive tumor with a poor prognosis due to its late
clinical presentation and the lack of effective non-surgical therapies. Unfortunately, most of …
clinical presentation and the lack of effective non-surgical therapies. Unfortunately, most of …
[HTML][HTML] Biomarkers for EMT and MET in breast cancer: An update
F Liu, LN Gu, BE Shan, CZ Geng… - Oncology …, 2016 - spandidos-publications.com
Metastasis and recurrence are the leading cause of mortality due to breast cancer, but the
underlying mechanisms are still poorly understood. Understanding the breast cancer …
underlying mechanisms are still poorly understood. Understanding the breast cancer …
Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment
R Portillo-Lara, N Annabi - Lab on a chip, 2016 - pubs.rsc.org
More than 90% of cancer-related deaths can be attributed to the occurrence of metastatic
diseases. Recent studies have highlighted the importance of the multicellular, biochemical …
diseases. Recent studies have highlighted the importance of the multicellular, biochemical …
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
Y Zhao, Y Li, J Sheng, F Wu, K Li, R Huang… - Journal of Experimental …, 2019 - Springer
Background TP53 is one of the most frequently mutated genes among all cancer types, and
TP53 mutants occur more than 60% in colorectal cancer (CRC). Among all mutants, there …
TP53 mutants occur more than 60% in colorectal cancer (CRC). Among all mutants, there …
Clinical relevancy of circulating tumor cells in breast cancer: epithelial or mesenchymal characteristics, single cells or clusters?
I Fridrichova, L Kalinkova, S Ciernikova - International Journal of …, 2022 - mdpi.com
Metastatic breast cancer (MBC) is typically an incurable disease with high mortality rates;
thus, early identification of metastatic features and disease recurrence through precise …
thus, early identification of metastatic features and disease recurrence through precise …
MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer
Y Lei, L Chen, G Zhang, A Shan, C Ye… - Oncology …, 2020 - spandidos-publications.com
Abstract Epithelial‑mesenchymal transition (EMT), during which cancer cells lose the
epithelial phenotype and gain the mesenchymal phenotype, has been verified to result in …
epithelial phenotype and gain the mesenchymal phenotype, has been verified to result in …
Fisetin inhibited growth and metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via PTEN/Akt/GSK3β signal pathway
J Li, X Gong, R Jiang, D Lin, T Zhou, A Zhang… - Frontiers in …, 2018 - frontiersin.org
Triple negative breast cancer (TNBC), characterized by its highly aggressive and metastatic
features, is associated with poor prognosis and high mortality partly due to lack of effective …
features, is associated with poor prognosis and high mortality partly due to lack of effective …